Overview of Cancer Profiling Market with Key Market Drivers, Challenges, Enabling Technologies, Revenue Potential, Vendor Profiles and their Key Strategies 2017-26

Recently, a novel report developed using proven research methodologies at the headquarters of Fact. MR has identified various prominent factors and trends prompting market growth of the global cancer profiling market. The study is titled as “Cancer Profiling Market Research Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026”, which deeply analyses the global market trends, with historical data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) during the mentioned forecast of 2017-2026. For the benefit of the readers, the report concludes with a special focus on the detailed profiles of the major vendors in the global cancer profiling market.

Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=358

As per the research report compiled by Fact.MR, the global cancer profiling market is expected to witness strong growth, registering 17.7% CAGR during the forecast period 2017-2026. By the end of 2026, the global cancer profiling market is estimated to reach US$ 122,129.6 million revenue. Increasing incidences of new cases of cancer are resulting in the rising use of cancer profiling. As per National Cancer Institute, new cancer cases are likely to reach 22 million within next two years. Moreover, increasing adoption of precision medicine treatment is also driving the demand for cancer profiling. Below are the few insights on how the global cancer profiling market will perform in the coming years.

Cancer profiling has emerged as one of the leading approaches used in identification, prognosis, research analysis and treatment of various cancers. Various approaches such as proteomics, genomics, and metabolomics are being used in cancer profiling. Also, precision medicine treatment is being adopted on a large scale in order to analyze individual genetic profiles and offer personalized treatments. Moreover, cancer is the focus of precision medicine. Moreover, around 631 cancer therapies are in the global oncology research and development pipeline. Next-generation sequencing in the cancer profiling is helping in identifying multiple tumor mutations. Many cancer centers have already adopted next-gen sequencing-based genetic profiling using target gene capturing. Oncologists across the world are using cancer profiling method along with the rise in adoption of cancer biomarkers for tumor profiling. Moreover, factors including point-of-care diagnostic test, and rising demand for personalized medicine is offering opportunities for leading companies in the cancer profiling market.

The report has also profiled leading players in the global market for cancer profiling, which will remain active through 2026. These include companies such as Roche Holdings, Caris Life Sciences, GenScript, Illumina, Inc. (U.S.), Proteome Sciences PLC, BioTheranostics, NeoGenomics Laboratories, RiboMed Biotechnologies Inc., Genomic Health Inc., Oxford Gene Technology Ltd., and Agendia.

Browse Full Report with TOC@ https://www.factmr.com/report/358/cancer-profiling-market

Table of Contents:

Global Economic Outlook
Global Cancer Profiling Market – Executive Summary
Global Cancer Profiling Market Overview
3.1. Introduction
3.1.1. Global Cancer Profiling Market Taxonomy
3.1.2. Global Cancer Profiling Market Definition
3.2. Global Cancer Profiling Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Cancer Profiling Market Y-o-Y Growth
3.3. Global Cancer Profiling Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Characteristics of Molecular Profiling Trials
3.7. Three-Tiered Approach for Reporting Biomarkers in Tumor Profiling NGS Tests
3.8. Recent breakthroughs in Cancer Profiling Market
3.9. Patent Analysis
3.10. Treatment Approvals
3.11. Cancer Epidemiology
3.12. PESTL Analysis
3.13. Product Lifecycle
3.14. Service Provider List
3.15. Key Participants Market Presence (Intensity Map) By Region
Global Cancer Profiling Market Analysis and Forecast 2012-2026
4.1. Global Cancer Profiling Market Size and Forecast By Technique, 2012-2026
4.1.1. Next-Generation Sequencing Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
Continued……..

Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=358

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Get More Industry Insights At: https://www.linkedin.com/company/factmr

This release was published on openPR.